Effects of nicotine dose and administration method on withdrawal symptoms and side effects during short-term smoking abstinence

Experimental and Clinical Psychopharmacology

Volumn 5, Issue 1, 1997, Pages 54-64

  Leischow, Scott J ^a   Valente, Suzanne N ^a   Hill, Anabel L ^a   Otte, Pamela S ^a   Aickin, Mikel ^a   Holden, Timothy ^a   Kligman, Evan ^a   Cook, Gretchen ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; NICOTINE; NICOTINE GUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INSOMNIA; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SMOKING CESSATION; TRANSDERMAL DRUG ADMINISTRATION; WITHDRAWAL SYNDROME;

ADMINISTRATION, CUTANEOUS; ADULT; AFFECT; BLOOD PRESSURE; CARBON MONOXIDE; CENTRAL NERVOUS SYSTEM STIMULANTS; CHEWING GUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; NICOTINE; NICOTINIC AGONISTS; POLYMETHACRYLIC ACIDS; POLYVINYLS; SALIVA; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0031035782     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.5.1.54     Document Type: Article

References (14)

1. Abelin, T., Buehler, A., Müller, P., Vesanen, K., & Imhoff, P. R. (1989). Controlled trial of transdermal nicotine patch in tobacco withdrawal. Lancet, 1, 7-10.
2. American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., rev.). Washington, DC: Author.
3. Fagerström, K. O., Schneider, N. G., & Lunnell, E. (1993). Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms. Psychopharmacology, 110, 271-277.
4. Fiore, M. C., Kenford, S. L., Jorenby, D. E., Wetter, D. W., Smith, S. S., & Baker, T. B. (1994). Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments. Chest, 105, 524-533.
5. Holm, S. (1979). A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics, 6, 65-70.
6. Hughes, J. R., & Hatsukami, D. (1986). Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry, 43, 289-294.
7. Hurt, R. D., Lauger, G. G., Offord, K. P., Kottke, T. E., & Dale, L. C. (1990). Nicotine replacement therapy with use of a transdermal nicotine patch - a randomized double-blind placebo-controlled trial. Mayo Clinical Proceedings, 65, 1529-1537.
8. Jarvis, M. J., Tunstall-Pedoe, H., Feyerabend, C., Vesey, C., & Saloojee, Y. (1987). Comparison of tests used to distinguish smokers from nonsmokers. American Journal of Public Health, 77, 1435-1438.
9. Killen, J. D., Fortmann, S. P., Newman, B., & Varady, A. (1990). Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. Journal of Consulting and Clinical Psychology, 58, 85-92.
10. Rose, J. E., Herskovic, J. E., Trilling, Y., & Jarvik, M. E. (1985). Transdermal nicotine reduces cigarette craving and nicotine preference. Clinical Pharmacology and Therapeutics, 38, 450-456.
11. Senf, J. H., Aickin, M., Bauman, K. A., & Allender, J. R. (1989). Attitude change: Measuring the effect of an educational program. Evaluation Review, 13, 550-556.
12. Tønnesen, P., Fryd, V., Hansen, M., Helsted, J., Gunnersen, A. B., Forchammer, H., & Stockner, M. (1988). Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking. New England Journal of Medicine, 318, 15-18.
13. Tønnesen, P., Norregaard, J., Simonsen, K., & Sawe, U. (1991). Double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. New England Journal of Medicine, 325, 311-315.
14. Wetter, D. W., Fiore, M. C., Baker, T. B., & Young, T. B. (1995). Tobacco withdrawal and nicotine replacement influence objective measures of sleep. Journal of Consulting and Clinical Psychology, 63(4), 658-667.